NeuroPace, Inc. (NPCE)
14.90
+0.15
(+1.02%)
USD |
NASDAQ |
Sep 04, 16:00
14.87
-0.03
(-0.20%)
Pre-Market: 20:00
NeuroPace Cash and Short Term Investments (Annual) : 61.06M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 61.06M |
| December 31, 2024 | 52.76M |
| December 31, 2023 | 66.45M |
| December 31, 2022 | 77.41M |
| Date | Value |
|---|---|
| December 31, 2021 | 115.58M |
| December 31, 2020 | 38.08M |
| December 31, 2019 | 5.092M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Tandem Diabetes Care, Inc. | 292.67M |
| CVRx, Inc. | 75.71M |
| Accuray, Inc. | 41.23M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 85.12M |